Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-14

Clinical Trial Update: A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of zonisamide for migraine headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Elan Pharmaceuticals | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED